id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2018-N-4627-0018,FDA,FDA-2018-N-4627,Letter from Medical Device Manufacturers Association to FDA DDM,Other,Letter(s),2019-05-01T04:00:00Z,2019,5,2019-05-01T04:00:00Z,,2019-05-01T20:08:55Z,,0,0,0900006483c259c3
FDA-2018-N-4627-0017,FDA,FDA-2018-N-4627,Altman - Review of the Mechanisms of Action for Supartz FX in Knee Osteoarthritis (2018),Supporting & Related Material,Background Material,2019-03-29T04:00:00Z,2019,3,,,2019-03-29T20:37:58Z,,0,0,0900006483b4c012
FDA-2018-N-4627-0008,FDA,FDA-2018-N-4627,Nicholls 2017,Supporting & Related Material,Background Material,2019-03-29T04:00:00Z,2019,3,,,2019-03-29T20:37:51Z,,0,0,0900006483b4c022
FDA-2018-N-4627-0005,FDA,FDA-2018-N-4627,Docket No. FDA-2018-N-4627 Reference List,Supporting & Related Material,Background Material,2019-03-29T04:00:00Z,2019,3,,,2019-03-29T20:37:49Z,,0,0,0900006483b4c050
FDA-2018-N-4627-0004,FDA,FDA-2018-N-4627,Richards 2016,Supporting & Related Material,Background Material,2019-03-29T04:00:00Z,2019,3,,,2019-03-29T20:37:48Z,,0,0,0900006483b4c1ff
FDA-2018-N-4627-0007,FDA,FDA-2018-N-4627,Trouvin - pain in OA - implications for optimal mgt,Supporting & Related Material,Background Material,2019-03-29T04:00:00Z,2019,3,,,2019-03-29T20:37:50Z,,0,0,0900006483b4c023
FDA-2018-N-4627-0013,FDA,FDA-2018-N-4627,Greenberg - Biochemical Effects of Two Different Hyaluronic Acid Products in a Co-Culture Model of Osteoarthritis (2006),Supporting & Related Material,Background Material,2019-03-29T04:00:00Z,2019,3,,,2019-03-29T20:37:55Z,,0,0,0900006483b4c016
FDA-2018-N-4627-0016,FDA,FDA-2018-N-4627,Altman - The Mechanism of Action for Hyaluronic Acid Treatment in the Osteoarthritic Knee - A Systematic Review (2015),Supporting & Related Material,Background Material,2019-03-29T04:00:00Z,2019,3,,,2019-03-29T20:37:57Z,,0,0,0900006483b4c013
FDA-2018-N-4627-0011,FDA,FDA-2018-N-4627,Liao - hyaluronan - pharmacological characterization and drug delivery,Supporting & Related Material,Background Material,2019-03-29T04:00:00Z,2019,3,,,2019-03-29T20:37:53Z,,0,0,0900006483b4c018
FDA-2018-N-4627-0002,FDA,FDA-2018-N-4627,Strauss - HA viscosupplementation and OA,Supporting & Related Material,Background Material,2019-03-29T04:00:00Z,2019,3,,,2019-03-29T20:37:46Z,,0,0,0900006483b4c201
FDA-2018-N-4627-0015,FDA,FDA-2018-N-4627,Balazs - Physical Properties of Synovial Fluid and the Special Role of Hyaluronic Acid,Supporting & Related Material,Background Material,2019-03-29T04:00:00Z,2019,3,,,2019-03-29T20:37:56Z,,0,0,0900006483b4c014
FDA-2018-N-4627-0003,FDA,FDA-2018-N-4627,Schaible2009_Article_JointPain,Supporting & Related Material,Background Material,2019-03-29T04:00:00Z,2019,3,,,2019-03-29T20:37:47Z,,0,0,0900006483b4c200
FDA-2018-N-4627-0006,FDA,FDA-2018-N-4627,Vasi - chemical functionalization of HA for drug delivery applications,Supporting & Related Material,Background Material,2019-03-29T04:00:00Z,2019,3,,,2019-03-29T20:37:49Z,,0,0,0900006483b4c024
FDA-2018-N-4627-0010,FDA,FDA-2018-N-4627,Migliore,Supporting & Related Material,Background Material,2019-03-29T04:00:00Z,2019,3,,,2019-03-29T20:37:52Z,,0,0,0900006483b4c019
FDA-2018-N-4627-0014,FDA,FDA-2018-N-4627,Chen 2018,Supporting & Related Material,Background Material,2019-03-29T04:00:00Z,2019,3,,,2019-03-29T20:37:56Z,,0,0,0900006483b4c015
FDA-2018-N-4627-0012,FDA,FDA-2018-N-4627,Jahn - Lubrication of Articular Cartilage (2016),Supporting & Related Material,Background Material,2019-03-29T04:00:00Z,2019,3,,,2019-03-29T20:37:54Z,,0,0,0900006483b4c017
FDA-2018-N-4627-0009,FDA,FDA-2018-N-4627,Moreland - intra-articular HA etc,Supporting & Related Material,Background Material,2019-03-29T04:00:00Z,2019,3,,,2019-03-29T20:37:51Z,,0,0,0900006483b4c021
FDA-2018-N-4627-0001,FDA,FDA-2018-N-4627,Intent To Consider the Appropriate Classification of Hyaluronic Acid Intraarticular Products Intended for the Treatment of Pain in Osteoarthritis of the Knee Based on Scientific Evidence,Notice,Announcement,2018-12-18T05:00:00Z,2018,12,2018-12-18T05:00:00Z,,2018-12-18T13:45:44Z,2018-27351,0,0,09000064839a90fa